97 related articles for article (PubMed ID: 23123726)
1. Design, synthesis and biological evaluation of new peptide-based ureas and thioureas as potential antagonists of the thrombin receptor PAR1.
Ventosa-Andrés P; Valdivielso AM; Pappos I; García-López MT; Tsopanoglou NE; Herranz R
Eur J Med Chem; 2012 Dec; 58():98-111. PubMed ID: 23123726
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation.
Wu CC; Teng CM
Eur J Pharmacol; 2006 Sep; 546(1-3):142-7. PubMed ID: 16890935
[TBL] [Abstract][Full Text] [Related]
3. Highly functionalized 2-oxopiperazine-based peptidomimetics: an approach to PAR1 antagonists.
Valdivielso ÁM; Ventosa-Andrés P; Tato F; Fernández-Ibañez MÁ; Pappos I; Tsopanoglou NE; García-López MT; Gutiérrez-Rodríguez M; Herranz R
Eur J Med Chem; 2013; 70():199-224. PubMed ID: 24158013
[TBL] [Abstract][Full Text] [Related]
4. Protease-activated receptor-2 (PAR-2): structure-function study of receptor activation by diverse peptides related to tethered-ligand epitopes.
Maryanoff BE; Santulli RJ; McComsey DF; Hoekstra WJ; Hoey K; Smith CE; Addo M; Darrow AL; Andrade-Gordon P
Arch Biochem Biophys; 2001 Feb; 386(2):195-204. PubMed ID: 11368342
[TBL] [Abstract][Full Text] [Related]
5. Exploring the Phe-Gly dipeptide-derived piperazinone scaffold in the search for antagonists of the thrombin receptor PAR1.
Valdivielso ÁM; García-López MT; Gutiérrez-Rodríguez M; Herranz R
Molecules; 2014 Apr; 19(4):4814-46. PubMed ID: 24743938
[TBL] [Abstract][Full Text] [Related]
6. The preparation and characterization of novel peptide antagonists to thrombin and factor VIIa and activation of protease-activated receptor 1.
Nieman MT; Warnock M; Hasan AA; Mahdi F; Lucchesi BR; Brown NJ; Murphey LJ; Schmaier AH
J Pharmacol Exp Ther; 2004 Nov; 311(2):492-501. PubMed ID: 15210836
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of piperazinyl carbamates and ureas as fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channel dual ligands.
Morera E; De Petrocellis L; Morera L; Moriello AS; Ligresti A; Nalli M; Woodward DF; Di Marzo V; Ortar G
Bioorg Med Chem Lett; 2009 Dec; 19(23):6806-9. PubMed ID: 19875281
[TBL] [Abstract][Full Text] [Related]
8. Non-peptidic small-molecule antagonists of the human platelet thrombin receptor PAR-1.
Selnick HG; Barrow JC; Nantermet PG; Connolly TM
Curr Med Chem Cardiovasc Hematol Agents; 2003 Mar; 1(1):47-59. PubMed ID: 15317290
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of non-peptide PAR1 thrombin receptor antagonists based on small bifunctional templates: arginine and phenylalanine side chain groups are keys for receptor activity.
Androutsou ME; Saifeddine M; Hollenberg MD; Matsoukas J; Agelis G
Amino Acids; 2010 Apr; 38(4):985-90. PubMed ID: 19484400
[TBL] [Abstract][Full Text] [Related]
10. Effect of aprotinin and recombinant variants on platelet protease-activated receptor 1 activation.
Day JR; Haskard DO; Taylor KM; Landis RC
Ann Thorac Surg; 2006 Feb; 81(2):619-24. PubMed ID: 16427862
[TBL] [Abstract][Full Text] [Related]
11. Identification of an active metabolite of PAR-1 antagonist RWJ-58259 and synthesis of analogues to enhance its metabolic stability.
Robinson E; Knight E; Smoktunowicz N; Chambers RC; Inglis GG; Chudasama V; Caddick S
Org Biomol Chem; 2016 Mar; 14(12):3198-201. PubMed ID: 26927018
[TBL] [Abstract][Full Text] [Related]
12. Discovery of potent peptide-mimetic antagonists for the human thrombin receptor, protease-activated receptor-1 (PAR-1).
Maryanoff BE; Zhang HC; Andrade-Gordon P; Derian CK
Curr Med Chem Cardiovasc Hematol Agents; 2003 Mar; 1(1):13-36. PubMed ID: 15317288
[TBL] [Abstract][Full Text] [Related]
13. Blockade of the thrombin receptor protease-activated receptor-1 with a small-molecule antagonist prevents thrombus formation and vascular occlusion in nonhuman primates.
Derian CK; Damiano BP; Addo MF; Darrow AL; D'Andrea MR; Nedelman M; Zhang HC; Maryanoff BE; Andrade-Gordon P
J Pharmacol Exp Ther; 2003 Feb; 304(2):855-61. PubMed ID: 12538843
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and pharmacological evaluation of peptide-mimetic protease-activated receptor-1 antagonists containing novel heterocyclic scaffolds.
Severino B; Fiorino F; Perissutti E; Frecentese F; Cirino G; Roviezzo F; Santagada V; Caliendo G
Bioorg Med Chem; 2008 Jun; 16(11):6009-20. PubMed ID: 18477511
[TBL] [Abstract][Full Text] [Related]
15. RWJ-58259: a selective antagonist of protease activated receptor-1.
Damiano BP; Derian CK; Maryanoff BE; Zhang HC; Gordon PA
Cardiovasc Drug Rev; 2003; 21(4):313-26. PubMed ID: 14647534
[TBL] [Abstract][Full Text] [Related]
16. Proteinase-activated receptors (PARs)--the PAR3 Neo-N-terminal peptide TFRGAP interacts with PAR1.
Kaufmann R; Schulze B; Krause G; Mayr LM; Settmacher U; Henklein P
Regul Pept; 2005 Feb; 125(1-3):61-6. PubMed ID: 15582715
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of PAR4 signaling mediates ethanol-induced attenuation of platelet function in vitro.
Kasuda S; Sakurai Y; Shima M; Morimura Y; Kudo R; Takeda T; Ishitani A; Yoshioka A; Hatake K
Alcohol Clin Exp Res; 2006 Sep; 30(9):1608-14. PubMed ID: 16930224
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of proteinase-activated receptor-1 (PAR1) agonists and antagonists using a cultured cell receptor desensitization assay: activation of PAR2 by PAR1-targeted ligands.
Kawabata A; Saifeddine M; Al-Ani B; Leblond L; Hollenberg MD
J Pharmacol Exp Ther; 1999 Jan; 288(1):358-70. PubMed ID: 9862790
[TBL] [Abstract][Full Text] [Related]
19. Discovery and synthesis of a novel series of quinoline-based thrombin receptor (PAR-1) antagonists.
Clasby MC; Chackalamannil S; Czarniecki M; Doller D; Eagen K; Greenlee WJ; Lin Y; Tsai H; Xia Y; Ahn HS; Agans-Fantuzzi J; Boykow G; Chintala M; Foster C; Bryant M; Lau J
Bioorg Med Chem Lett; 2006 Mar; 16(6):1544-8. PubMed ID: 16380251
[TBL] [Abstract][Full Text] [Related]
20. Exploration of a new series of PAR1 antagonists.
Planty B; Pujol C; Lamothe M; Maraval C; Horn C; Le Grand B; Perez M
Bioorg Med Chem Lett; 2010 Mar; 20(5):1735-9. PubMed ID: 20137929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
